(Q46804582)

English

[(11)C]choline uptake with PET/CT for the initial diagnosis of prostate cancer: relation to PSA levels, tumour stage and anti-androgenic therapy

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18200444

[(11)C]choline uptake with PET/CT for the initial diagnosis of prostate cancer: relation to PSA levels, tumour stage and anti-androgenic therapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18200444

prostate cancer

1 reference

based on heuristic

inferred from title

2

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18200444

Cesare Cozzarini

object named as

Cesare Cozzarini

6

0 references

author name string

Giampiero Giovacchini

1

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18200444

Elisa Coradeschi

3

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18200444

Vincenzo Scattoni

4

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18200444

Valentino Bettinardi

5

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18200444

Massimo Freschi

7

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18200444

Ferruccio Fazio

8

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18200444

Cristina Messa

9

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18200444

publication date

16 January 2008

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18200444

number of pages

9

1 reference

based on heuristic

inferred from page(s)

European Journal of Nuclear Medicine and Molecular Imaging

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18200444

35

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18200444

6

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18200444

1065-1073

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18200444

https://scigraph.springernature.com/pub.10.1007/s00259-008-0716-2

0 references

Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24-0.7-cm3) spatial resolution

1 reference

https://api.crossref.org/works/10.1007%2FS00259-008-0716-2

21 January 2018

Prostate cancer localization with 18fluorine fluorocholine positron emission tomography.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-008-0716-2

21 January 2018

Effects of androgen deprivation on prostatic morphology and vascular permeability evaluated with mr imaging

1 reference

https://api.crossref.org/works/10.1007%2FS00259-008-0716-2

21 January 2018

Effects of 2-methoxyestradiol on proliferation, apoptosis and PET-tracer uptake in human prostate cancer cell aggregates.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18200444

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

MicroPET assessment of androgenic control of glucose and acetate uptake in the rat prostate and a prostate cancer tumor model

1 reference

https://pubmed.ncbi.nlm.nih.gov/18200444

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

11C-choline positron emission tomography in prostate cancer: primary staging and recurrent site staging

1 reference

https://pubmed.ncbi.nlm.nih.gov/18200444

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of hormonal treatment in prostate cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18200444

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative assessment of the 1992 and 2002 pathologic T3 substages for the prediction of biochemical recurrence after radical prostatectomy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18200444

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dietary choline: biochemistry, physiology, and pharmacology

1 reference

https://pubmed.ncbi.nlm.nih.gov/18200444

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preoperative staging of pelvic lymph nodes in prostate cancer by 11C-choline PET.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18200444

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of serum prostate-specific antigen velocity after radical prostatectomy to distinguish local recurrence from distant metastases

1 reference

https://pubmed.ncbi.nlm.nih.gov/18200444

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predictors of metastatic disease in men with biochemical failure following radical prostatectomy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18200444

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of hypoxia on the uptake of [methyl-3H]choline, [1-14C] acetate and [18F]FDG in cultured prostate cancer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/18200444

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fluorocholine PET/CT in patients with prostate cancer: initial experience

1 reference

https://pubmed.ncbi.nlm.nih.gov/18200444

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Time-dependent effects of hormone-deprivation therapy on prostate metabolism as detected by combined magnetic resonance imaging and 3D magnetic resonance spectroscopic imaging

1 reference

https://pubmed.ncbi.nlm.nih.gov/18200444

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Blood metabolism of [methyl- 11C]choline; implications for in vivo imaging with positron emission tomography

1 reference

https://pubmed.ncbi.nlm.nih.gov/18200444

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vivo uptake of [11C]choline does not correlate with cell proliferation in human prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18200444

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Histopathological changes in androgen-deprived localized prostatic cancer. A study in total prostatectomy specimens

1 reference

https://pubmed.ncbi.nlm.nih.gov/18200444

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of endocrine therapy on the primary lesion in patients with prostate carcinoma as evaluated by endorectal magnetic resonance imaging

1 reference

https://pubmed.ncbi.nlm.nih.gov/18200444

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predicting radionuclide bone scan findings in patients with newly diagnosed, untreated prostate cancer: prostate specific antigen is superior to all other clinical parameters

1 reference

https://pubmed.ncbi.nlm.nih.gov/18200444

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Experience with carbon-11 choline positron emission tomography in prostate carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/18200444

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

11C-choline positron emission tomography/computerized tomography for tumor localization of primary prostate cancer in comparison with 12-core biopsy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18200444

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Androgens and the control of lipid metabolism in human prostate cancer cells.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18200444

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Value of 11C-choline PET and PET/CT in patients with suspected prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18200444

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radiolabeled choline as a proliferation marker: comparison with radiolabeled acetate

1 reference

https://pubmed.ncbi.nlm.nih.gov/18200444

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Kinetics of [(11)C]choline uptake in prostate cancer: a PET study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18200444

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detection of increased choline compounds with proton nuclear magnetic resonance spectroscopy subsequent to malignant transformation of human prostatic epithelial cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/18200444

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Monitoring of therapy in androgen-dependent prostate tumor model by measuring tumor proliferation.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18200444

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Overexpression of choline kinase is a frequent feature in human tumor-derived cell lines and in lung, prostate, and colorectal human cancers

1 reference

https://pubmed.ncbi.nlm.nih.gov/18200444

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Positron emission tomography of a human prostate cancer xenograft: association of changes in deoxyglucose accumulation with other measures of outcome following androgen withdrawal

1 reference

https://pubmed.ncbi.nlm.nih.gov/18200444

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influence of capsular penetration on progression following radical prostatectomy: a study of 196 cases with long-term followup

1 reference

https://pubmed.ncbi.nlm.nih.gov/18200444

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

FDG PET for evaluating the change of glucose metabolism in prostate cancer after androgen ablation.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18200444

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

PET imaging of prostate cancer using carbon-11-choline.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18200444

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Value of [11C]choline-positron emission tomography for re-staging prostate cancer: a comparison with [18F]fluorodeoxyglucose-positron emission tomography.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18200444

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Visualization of prostate cancer with 11C-choline positron emission tomography

1 reference

https://pubmed.ncbi.nlm.nih.gov/18200444

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Imaging prostate cancer with 11C-choline PET/CT.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18200444

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic significance of positive surgical margins in patients with extraprostatic carcinoma after radical prostatectomy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18200444

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prostate cancer: a comparative study of 11C-choline PET and MR imaging combined with proton MR spectroscopy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18200444

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Localization of primary prostate cancer with dual-phase 18F-fluorocholine PET.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18200444

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neoadjuvant therapy and prostate cancer: what a urologist should know

1 reference

https://pubmed.ncbi.nlm.nih.gov/18200444

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bicalutamide ('Casodex') 150 mg as adjuvant to radiotherapy in patients with localised or locally advanced prostate cancer: results from the randomised Early Prostate Cancer Programme

1 reference

https://pubmed.ncbi.nlm.nih.gov/18200444

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detection and localization of prostate cancer: correlation of (11)C-choline PET/CT with histopathologic step-section analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18200444

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00259-008-0716-2

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18200444

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18200444

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46804582&oldid=2133064124"